… Drug-resistant herpesviruses are found relatively … antiviral therapy. For instance, close
to 10% of patients with AIDS receiving intravenous ganciclovir for 3 months excrete a drug-…

The current armamentarium for the chemotherapy of viral infections consists of 37 licensed
antiviral drugs. For the treatment of human immunodeficiency virus (HIV) infections, 19 …

… resistance range from toxicity inherent in use of second-line antivirals, to severe disease …
to antiviral drugs used to treat several viral infections that play a significant role in the clinical …

… Several repurposed drugs have been assessed clinically, … New antiviral drugs targeting
different SARS-CoV-2 enzymes … will see the impact of these newly developed drugs on COVID-19…

… However, 2 groups of antiviral drugs are available for the treatment and prophylaxis of …
. Estimated impact of different sizes of antiviral stockpiles on the number of clinical cases at …

… Thus, the clinical impact of new drugs depended on the number of previous drugs used. VL
and CD4 cell counts measured during follow-up were available for 976 patients. The median …

… summarized the epidemiological and clinical data from several clinical trials conducted since
… The restrictions on travel and businesses significantly impacted the economic condition, …

… highlights the gaps in our knowledge of the impacts of antiretroviral drugs on autophagy. …
impact of antiretroviral drugs on autophagy as they relate to clinical side effects and toxicities. …

… time, susceptibility to additional antiviral agents is reduced or duration of treatment is
suboptimal. In this review geno- and phenotypic resistance testing as well as clinical data on the …

… Increasingly, the management of comorbidities, polypharmacy, and drug–drug interaction,
and their impact on antiretroviral therapy will have to be undertaken. These clinical settings …